Your browser doesn't support javascript.
loading
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
French, Jacqueline A; Porter, Roger J; Perucca, Emilio; Brodie, Martin J; Rogawski, Michael A; Pimstone, Simon; Aycardi, Ernesto; Harden, Cynthia; Qian, Jenny; Rosenblut, Constanza Luzon; Kenney, Christopher; Beatch, Gregory N.
Afiliação
  • French JA; New York University Comprehensive Epilepsy Center, New York, New York.
  • Porter RJ; Department of Neurology, University of Pennsylvania, Philadelphia.
  • Perucca E; Department of Medicine (Austin Health), The University of Melbourne, Melbourne, Victoria, Australia.
  • Brodie MJ; Department of Neuroscience, Monash University, Melbourne, Victoria, Australia.
  • Rogawski MA; University Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland, United Kingdom.
  • Pimstone S; School of Medicine, University of California, Davis, Sacramento.
  • Aycardi E; Xenon Pharmaceuticals, Vancouver, British Columbia, Canada.
  • Harden C; Xenon Pharmaceuticals, Vancouver, British Columbia, Canada.
  • Qian J; Xenon Pharmaceuticals, Vancouver, British Columbia, Canada.
  • Rosenblut CL; Xenon Pharmaceuticals, Vancouver, British Columbia, Canada.
  • Kenney C; Xenon Pharmaceuticals, Vancouver, British Columbia, Canada.
  • Beatch GN; Xenon Pharmaceuticals, Vancouver, British Columbia, Canada.
JAMA Neurol ; 80(11): 1145-1154, 2023 Nov 01.
Article em En | MEDLINE | ID: mdl-37812429

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsias Parciais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Neurol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epilepsias Parciais Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: JAMA Neurol Ano de publicação: 2023 Tipo de documento: Article